Wego Together with Wegovy: What Joining a Semaglutide Programme Actually Looks Like

Step 1, Clinical assessment before anything else

Before a single pen is dispensed, a prescriber reads your health history. At nume, that means a GPhC-registered Independent Prescriber reviews your consultation the same day you submit it, a real clinician, reading your answers, not software sorting a queue. They check BMI, existing conditions, current medicines, and whether any contraindications apply.

Some situations require extra thought: if you take an oral contraceptive pill, for instance, NHS England's guidance on weight-management injections notes that tirzepatide can reduce pill absorption, and a similar conversation is worth having about semaglutide. Pregnancy, breastfeeding, or actively trying to conceive means Wegovy is not appropriate, that comes up at the assessment stage. The prescriber also screens for a history of pancreatitis and certain gastrointestinal conditions that would change the clinical picture.

If you are moving across from another provider, the prescriber will want to see evidence of your current dose and treatment history. That paperwork step protects you: it rules out starting someone mid-titration at a dose their system hasn't been prepared for. Our clinical team covers exactly this kind of transfer assessment.

Step 2, Identity, weight verification, and dispatch

Once the prescriber approves treatment, two further checks happen before dispatch: photo-ID identity verification and live weight verification by video. Both exist to protect against prescriptions reaching people whose circumstances the prescriber hasn't actually seen. It adds a few minutes. It also means the starting dose is matched to a person who has genuinely been assessed, not a name on a form.

Order by midday Monday to Friday and, once clinically approved, your treatment leaves the same day. DPD delivers the next working day in plain, unbranded packaging, tracked to your phone. If your order lands on a Friday afternoon or around a bank holiday, it ships the next available working day; worth keeping in mind if you are timing your first pen around payday or a Monday restart.

Sharps disposal is part of responsible use from day one. The Wegovy overview covers the practicalities of handling and storing your pens correctly.

Step 3 (Titration, side effects, and knowing when to call someone

Wegovy starts at 0.25 mg) a tolerability dose while your gut adjusts to semaglutide, not the dose doing the primary clinical work. Your prescriber steps the dose upward roughly every four weeks. Common side effects during titration are gastrointestinal: nausea, loose stools, constipation, bloating, and sometimes fatigue. Most settle within days to a couple of weeks after each increase, and they are generally less noticeable at lower doses.

Two situations call for prompt medical attention rather than waiting it out. Severe, persistent stomach pain that radiates toward the back (with or without vomiting) should be assessed urgently, given what the MHRA's updated guidance says about the risk of acute pancreatitis with GLP-1 medicines. Signs of serious dehydration (inability to keep fluids down for more than a day) also warrant a call to 111 or your GP rather than pushing through. The weight-loss treatment overview includes a fuller picture of what to monitor during treatment.

For patients on HRT, how Wegovy and HRT interact is worth reading before you start, NHS guidance specifically flags transdermal forms as worth considering when GLP-1 treatment is in the picture.

Step 4, Ongoing review and what happens at each repeat order

There are no subscriptions here. Every repeat order at nume goes through a fresh clinical review before it ships, the prescriber is not rubber-stamping what went before but actively checking whether the current dose is still appropriate, whether side effects have settled, and whether any new health information has come in. That matters over the course of a titration schedule that can span several months.

Cost is a reasonable question at this stage. Wegovy is a private prescription medicine, and treatment pricing has moved since Eli Lilly's 2025 list-price changes reshaped the market (that affected Mounjaro specifically, but private semaglutide pricing reflects the wider supply picture too). A full breakdown of what's involved and what that typically covers is on the Wegovy sourcing and cost page. At nume, one price covers the consultation, the prescription, delivery, and seven-day-a-week aftercare, no separate line items added later.

Questions about medicines that shouldn't be combined with semaglutide come up regularly. The page on taking Saxenda and Wegovy together addresses the dual-GLP-1 question directly, the short answer is that combining them is not appropriate, but the nuances are worth reading. Similarly, the semaglutide information page covers the medicine's broader clinical profile if you want the pharmacology before your consultation.

When you feel ready to begin, speak to our prescribers through a free consultation, the same day, the same clinical rigour, no waiting list. If you would like to understand how the We Go Together Wegovy programme fits into your treatment journey, that page sets out the support structure in full.